Hematopoietic stem cell cytokine control of developmental vascularization
Hematopoietic stem cell cytokine control of developmental vascularization
批准号:
8021934
负责人:
George E Davis
金额:
$37.88万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-03 至 2014-12-31
关键词:
AbdomenAddressAffectAngiopoietinsAortaBasement membraneBindingBiological AssayBlocking AntibodiesBlood CellsBlood VesselsBrainCD80 geneCXCR4 geneCardiovascular DiseasesCell LineCell ProliferationCell SurvivalCollagenComplexCytokine ReceptorsDataDefectDevelopmentDevelopmental ProcessDiabetes MellitusDorsalEmbryoEndothelial CellsEventExtracellular MatrixFibrinGrowthGrowth FactorHematopoiesisHematopoieticHematopoietic stem cellsHemorrhageHumanIn VitroIntegrinsInterleukin-3LaboratoriesLigandsLinkMalignant NeoplasmsMediator of activation proteinMesenchymeModelingMolecularMorphogenesisPericytesPhenotypePhorbol EstersPhosphotransferasesPlatelet-Derived Growth FactorProcessProtein IsoformsProto-Oncogene Protein c-kitQuailScreening procedureSerumSerum-Free Culture MediaSignal TransductionStem Cell FactorStromal Cell-Derived Factor 1Supporting CellSystemTransforming Growth Factor betaTubeVascular Endothelial Growth FactorsVascularizationWorkbasebone morphogenic proteincell behaviorcofactorcytokinefascinatehuman diseasein vivoinhibitor/antagonistinterestmonolayernovelprecursor cellreceptorresponsestemsynergismvasculogenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In this new proposal, we investigate our novel finding that a unique combination of hematopoietic stem cell cytokines (i.e. stem cell factor-SCF; interleukin 3- IL-3; and stromal-derived factor-1 alpha- SDF-11) control human endothelial cell (EC) tube morphogenesis and EC-pericyte tube co assembly under defined serum-free conditions (and in the absence of phorbol ester) in 3D collagen matrices. Interestingly, VEGF has no influence by itself and requires the synergistic action of these hematopoietic factors in order to exert an effect on EC sprouting, its major morphogenic influence. We propose the hypothesis that SCF, IL-3 and SDF-11 are critical regulators of vascular morphogenesis which act in a synergistic manner and are necessary cofactors for the action of known mediators of developmental vascularization (e.g. VEGF and BMP-4). Combined administration of c-Kit (the SCF receptor) and CXCR4 (the SDF-11 receptor) inhibitors or blocking antibodies to SCF and IL-3 leads to vascular hemorrhage phenotypes in developing quail embryos that relates to defects in vessel formation and remodeling. Also, we show that the three factors synergize to activate Src, B-Raf and Erk kinases and induce the expression of the 1221 integrin and Pak2 which are known regulators of vascular morphogenesis. We will elucidate the molecular basis for the signaling synergism of the three cytokines in ECs, how these factors interface with VEGF, BMP-4, and pericytes to control EC sprouting and how they affect both ECs and pericytes during tube co assembly and maturation events in vitro and in vivo. We propose three specific aims which are; Specific Aim #1. To elucidate the signaling mechanisms by which SCF, IL-3 and SDF-11 synergize to stimulate vasculogenic EC tube assembly in 3D extracellular matrices. Specific Aim #2. To determine how SCF, IL-3 and SDF-11 affect VEGF and BMP-4 signaling to control EC sprouting responses in 3D extracellular matrices. Specific Aim #3. To determine how SCF, IL-3 and SDF-11 act to regulate pericyte-induced EC sprouting responses and vasculogenic EC-pericyte tube co assembly in 3D extracellular matrices.
PUBLIC HEALTH RELEVANCE: This work focuses on the ability of factors which are known to support the growth of immature blood cells to also be able to support the formation of blood vessels which carry blood cells. These factors bind to endothelial cells, which line blood vessels and to pericytes, a supporting cell that helps blood vessels form and become stable. A basic understanding of the mechanisms underlying how blood vessels form and become stabilized is critical in efforts to stimulate or inhibit the process in the context of various human diseases such as cardiovascular disease, diabetes or cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular basis for defective pericyte-endothelial cell interactions regulating vascular malformations
-
批准号:10192817
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2020
-
负责人:George E Davis
-
依托单位:
Molecular basis for defective pericyte-endothelial cell interactions regulating vascular malformations
-
批准号:10619624
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2020
-
负责人:George E Davis
-
依托单位:
Molecular basis for defective pericyte-endothelial cell interactions regulating vascular malformations
-
批准号:10408085
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2020
-
负责人:George E Davis
-
依托单位:
Novel growth factor and signaling requirements for human capillary tube assembly
-
批准号:9102169
-
项目类别:
-
资助金额:$38.37万
-
财政年份:2015
-
负责人:George E Davis
-
依托单位:
Novel growth factor and signaling requirements for human capillary tube assembly
-
批准号:8942261
-
项目类别:
-
资助金额:$39.7万
-
财政年份:2015
-
负责人:George E Davis
-
依托单位:
Hematopoietic stem cell cytokine control of developmental vascularization
-
批准号:8207865
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2011
-
负责人:George E Davis
-
依托单位:
Hematopoietic stem cell cytokine control of developmental vascularization
-
批准号:8593308
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2011
-
负责人:George E Davis
-
依托单位:
Hematopoietic stem cell cytokine control of developmental vascularization
-
批准号:8402619
-
项目类别:
-
资助金额:$36.06万
-
财政年份:2011
-
负责人:George E Davis
-
依托单位:
Molecular and Cellular Biology Core
-
批准号:7918622
-
项目类别:
-
资助金额:$13.7万
-
财政年份:2010
-
负责人:George E Davis
-
依托单位:
Molecular Control of EC Lumen Formation by MT1-MMP
-
批准号:7373336
-
项目类别:
-
资助金额:$37.36万
-
财政年份:2008
-
负责人:George E Davis
-
依托单位:
Molecular Control of EC Lumen Formation by MT1-MMP
-
批准号:7747956
-
项目类别:
-
资助金额:$37.18万
-
财政年份:2008
-
负责人:George E Davis
-
依托单位:
Molecular Control of EC Lumen Formation by MT1-MMP
-
批准号:7539910
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2008
-
负责人:George E Davis
-
依托单位:
Pericyte Proteinase Inhibitors and EC Tube Stabilization
-
批准号:7248339
-
项目类别:
-
资助金额:$28.42万
-
财政年份:2005
-
负责人:George E Davis
-
依托单位:
Pericyte Proteinase Inhibitors and EC Tube Stabilization
-
批准号:7009571
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2005
-
负责人:George E Davis
-
依托单位:
Pericyte proteinase inhibitors and EC tube stabilization
-
批准号:8397677
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2005
-
负责人:George E Davis
-
依托单位:
Pericyte proteinase inhibitors and EC tube stabilization
-
批准号:7782419
-
项目类别:
-
资助金额:$37.18万
-
财政年份:2005
-
负责人:George E Davis
-
依托单位:
Pericyte proteinase inhibitors and EC tube stabilization
-
批准号:8197535
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2005
-
负责人:George E Davis
-
依托单位:
Pericyte Proteinase Inhibitors and EC Tube Stabilization
-
批准号:6869858
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2005
-
负责人:George E Davis
-
依托单位:
Pericyte Proteinase Inhibitors and EC Tube Stabilization
-
批准号:7163001
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2005
-
负责人:George E Davis
-
依托单位:
Pericyte Proteinase Inhibitors and EC Tube Stabilization
-
批准号:7333270
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2005
-
负责人:George E Davis
-
依托单位:
海外基金